Overview

• The film has grossed about $230–235 million domestically and roughly $204.6 million internationally for a global total near $437 million.
• It suffered a roughly 61–66% second-weekend decline and a 59% drop in its third weekend, falling to No. 3 domestically and losing premium IMAX engagements.
• With production and marketing costs pushing the breakeven threshold toward $500 million, industry estimates warn its theatrical run may fall short of turning a profit.
• Despite an 86% Rotten Tomatoes critics’ score and a 91% audience rating, positive reception has not halted its rapid box office erosion.
• A mid-credits tease of Doctor Doom and early sequel planning underline its strategic role in Marvel’s Phase Six slate even as its theatrical future remains uncertain.